Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/29/2010 | CN101926763A Method for preparing lipoalprostadil sterile preparation |
12/29/2010 | CN101926762A Rupatadine fumarate eye drops and preparation method thereof |
12/29/2010 | CN101926761A Production method of compound potassium dihydrogn phosphate |
12/29/2010 | CN101926760A Dexamethasone injecta coated with 2-hydroxypropyl-beta-cyclodextrin |
12/29/2010 | CN101926759A Idebenone injection containing 2-hydroxylpropyl-beta-cyclodextrin and preparation method thereof |
12/29/2010 | CN101926758A Itraconazole suppository |
12/29/2010 | CN101926757A Liquid composition of indissolvable medicines and preparation method thereof |
12/29/2010 | CN101926756A Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof |
12/29/2010 | CN101926755A In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof |
12/29/2010 | CN101926508A Application of blackberrykiky rhizome in cigarette |
12/29/2010 | CN101703481B Ribavirin lipid microsphere effervescent granules |
12/29/2010 | CN101658526B Veterinary compound enrofloxacin injection and preparation method thereof |
12/29/2010 | CN101632671B Suspensoid powder injection of piperacillin sodium sulbactam sodium medicine composition and novel application thereof |
12/29/2010 | CN101623261B Cefamandole sodium proliposome preparation |
12/29/2010 | CN101623255B Artesunate nanoemulsion drug composition and preparation method thereof |
12/29/2010 | CN101618030B Triptolide transdermal patch and preparation method thereof |
12/29/2010 | CN101584669B Melphalan freeze-dried powder injection |
12/29/2010 | CN101564376B Decoquinate solid dispersoid and preparation method thereof |
12/29/2010 | CN101559043B Benzene sulfonic acid levo-amlodipine pill and preparation method thereof |
12/29/2010 | CN101524325B Compound menthol microemulsion and preparation for nose |
12/29/2010 | CN101502486B Antineoplastic 2-methoxyestradiol injection containing cyclodextrin or cyclodextrin derivates |
12/29/2010 | CN101491502B Cefuroxime sodium freeze dry power preparation method |
12/29/2010 | CN101444554B Snake-fat ointment and preparation method thereof |
12/29/2010 | CN101433654B Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
12/29/2010 | CN101422426B Nitroimidazoles medicine nano montmorillonite sustained-release agent and preparation method thereof |
12/29/2010 | CN101417132B Use of medicine combination comprising carvedilol and angiotensin II recipient antagonist in preparing medicine for treating kidney disease |
12/29/2010 | CN101406668B Chinese medicinal composition for treating headache and dizzy, and preparation method thereof |
12/29/2010 | CN101406591B Plaster for treating sore, carbuncle and painful swelling and preparation method thereof |
12/29/2010 | CN101396468B Traditional Chinese medicine for treating diabetes coronary heart disease |
12/29/2010 | CN101390980B External medicine for treating skin disease and preparation method thereof |
12/29/2010 | CN101390825B Intra-ocular release system of voriconazole |
12/29/2010 | CN101342357B Chinese medicinal composition for treating gland hyperplasia and preventing and controlling mammary cancer |
12/29/2010 | CN101336904B Acarbose chewable tablets and preparation method thereof |
12/29/2010 | CN101330906B Hcv prodrug formulation |
12/29/2010 | CN101317958B Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof |
12/29/2010 | CN101313953B Medicament composition for treating idiopathic thromboeytopenic purpura and preparation method thereof |
12/29/2010 | CN101301454B Navel plaster with powder for soothing heart |
12/29/2010 | CN101278934B Oral soft capsule compound preparations for curing cold |
12/29/2010 | CN101259191B Fat-reducing health products and producing method thereof |
12/29/2010 | CN101249209B Nosebleed stopping powder |
12/29/2010 | CN101244181B Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof |
12/29/2010 | CN101214332B Composition for treating asthmatic bronchitis and bronchial asthma and preparation thereof |
12/29/2010 | CN101209288B Corydalis decumbentis orally disintegrating tablets |
12/29/2010 | CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
12/29/2010 | CN101190289B Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain |
12/29/2010 | CN101181333B Chinese medicine injection for curing cardiovascular and cerebrovascular diseases as well as method for manufacture and detection thereof |
12/29/2010 | CN101146523B Transdermal delivery systems |
12/29/2010 | CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same |
12/29/2010 | CN101120784B Brain tonic food and preparation method thereof |
12/29/2010 | CN101007083B Medicine composition for treating acute and chronic rhinitis or sinusitis and its preparation method |
12/29/2010 | CA2766908A1 Chewable drug |
12/29/2010 | CA2766524A1 Method for treating a patient in need of aspirin therapy |
12/29/2010 | CA2766354A1 Topical composition containing ibuprofen |
12/29/2010 | CA2766291A1 Injectable formulations containing asenapine and method of treatment using same |
12/29/2010 | CA2766179A1 Controlled release formulations |
12/29/2010 | CA2766107A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition |
12/29/2010 | CA2765734A1 Implantable drug delivery devices and methods of making the same |
12/29/2010 | CA2765635A1 Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof |
12/29/2010 | CA2765630A1 Solid drug tablets for implantable drug delivery devices |
12/29/2010 | CA2764963A1 Method for treating a patient at risk for developing an nsaid-associated ulcer |
12/29/2010 | CA2764418A1 Cannula assembly for co-delivery of medicaments |
12/29/2010 | CA2764060A1 Topical compositions and methods for wound care |
12/29/2010 | CA2763299A1 Method for treating or ameliorating mucocutaneous or ocular toxicities |
12/29/2010 | CA2761427A1 A pharmaceutical composition |
12/29/2010 | CA2752865A1 Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent |
12/28/2010 | USRE42014 Pharmaceutical compositions |
12/28/2010 | USRE42012 Compositions and methods for enhancing receptor-mediated cellular internalization |
12/28/2010 | US7860545 Analyte measuring device |
12/28/2010 | US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage |
12/28/2010 | US7858656 Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation |
12/28/2010 | US7858597 formulations of ANGIOTENSIN II AT1 receptors antagonists, using the cyclodextrins or their derivatives, lipossomes and the biodegradable polymers; increasing the bio-availability of losartan |
12/28/2010 | US7858588 Oligodeoxynucleic acid modified with (thio)phosphate |
12/28/2010 | US7858585 A polypeptide hydrogel containing VKVKVKVKVDPPTKVEVKVKV amino acid sequence, that may be formed by the self-assembly of peptides in solution and brought about by a change of the hydrogel e.g. pH, ionic strength, temperature, concentration of specific ions; drug delivery; wound healing; tissue engineering |
12/28/2010 | US7858582 external preparation containing recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carrier; corneal lesions and corneal ulcers |
12/28/2010 | US7858183 increase in internal pressure eventually causes particle to burst (particle containing a gas generator e.g. water or saline), forming burst particle, and it releases ferromagnetic particles to deliver to unhealthyl tissue; drug delivery system |
12/28/2010 | US7858177 Microcapsule composition for electrophoretic displays |
12/28/2010 | US7858129 High gloss film coating and stable solution therefor |
12/28/2010 | US7858123 Inorganic materials for hemostatic modulation and therapeutic wound healing |
12/28/2010 | US7858122 tablet comprising water dispersible rate controlling polymer hydroxypropyl methylcellulose, and polyvinyl pyrrolidone; effective plasma levels over 24 hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients |
12/28/2010 | US7858121 Tablets; reduced side effects; cancer pain; substantially less fentanyl by weight than known oral formulation |
12/28/2010 | US7858120 use in veterinary medicine; improve the taste of pradofloxacin Quinolone antibiotics with a flavoring mixture of proteins, fats, and carbohydrates |
12/28/2010 | US7858119 Extended release pharmaceuticals |
12/28/2010 | US7858118 Useful for the post surgery pain control |
12/28/2010 | US7858117 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 7; stable at pH 4.2 and Ph 7.5; cationic lipid, anionic lipid, and neutral lipid; comprising cholesterol hemisuccinate |
12/28/2010 | US7858116 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment |
12/28/2010 | US7858115 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
12/28/2010 | US7858113 for transdermal delivery of active substances by means of a plaster which is transparent in some areas, contains active substance, and is flexible in some areas, and by means of an external light source focused onto the stratum corneum of the skin with the aid of a plurality of individual lenses |
12/28/2010 | US7858112 Portable medical equipment comprising drug reservoirs or containers, supports including adhesive layers and drug impervious substrates, used for delivery of high molecular weight drugs such as insulin, calcitionin or vasopressin |
12/28/2010 | US7858111 Polyester fiber; textiles which contains bactericides, fungicides, miticides additive |
12/28/2010 | US7858104 Cosmetic liquid foundation contains a dimethicone polyether copolymers, a hydrophobic coated pigment; free of polyglyceryl-4 isostearate or in a low quantity; spreading homogeneously, aesthetic quality, non-greasy, rapid drying; storage stability, easy to apply |
12/28/2010 | US7858085 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase |
12/28/2010 | US7858082 providing a bulk of monomeric protein in a buffer solution and adding an excipient selected from bacteriostatic agents, surfactants, isotonicity agents, amino acids, antioxidants and combinations thereof; refereably the monomeric protein is IFN-beta |
12/28/2010 | US7858030 Artificial lipid bilayer membrane formation device, artificial lipid bilayer membrane formation method, and usage thereof |
12/28/2010 | US7857244 Shape engineering of nanoparticles |
12/23/2010 | WO2010148352A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application |
12/23/2010 | WO2010148337A1 Lyophilized formulations for small modular immunopharmaceuticals |
12/23/2010 | WO2010148288A2 Pharmaceutical formulations with low aqueous levels of free unbound drug |
12/23/2010 | WO2010148190A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
12/23/2010 | WO2010148106A1 Systems and methods involving calcium phosphate based materials |
12/23/2010 | WO2010148007A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |